IL22 and cancer: Since STAT3/Akt signaling axis has been identified as crucial step in cancer development and progression, and been found to be a mediator of IL22-induced effects as well12, 25, 26, we detected the expression of downstream proteins in STAT3 signing including p-AKT, p-β-catenin,.